Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:08:38.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the usual study record content, indicating the page is currently inaccessible. The rendered page displays a generic error layout rather than the study details.
    Difference
    17%
    Check dated 2026-09-19T22:06:35.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a page revision or software update. This change does not modify the study details or other substantive content on the page.
    Difference
    0.0%
    Check dated 2026-08-29T18:32:55.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a new publication citation about BRAF p.V600E mutation monitoring in cerebrospinal fluid during BRAF/MEK inhibitor therapy for papillary craniopharyngioma to the study's publications section.
    Difference
    0.0%
    Check dated 2026-08-15T11:35:30.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor update to the page’s backend or content.
    Difference
    0.0%
    Check dated 2026-08-08T09:20:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, reflecting a new revision of the page without changes to study details or core content.
    Difference
    0.0%
    Check dated 2026-07-25T05:25:48.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.